MicroIslet and The Scripps Research Institute extend diabetes collaboration
5th Sep 2005, 13:33 GMT
MicroIslet and The Scripps Research Institute have extended their diabetes collaboration agreement for an additional two years. The organizations have been collaborating in the area of islet cell transplantation therapies for treatment of insulin-dependent diabetes.
Latest news from Pharmaceutical Business Review Online:
- Celesio revenues, profits up
- Amgen arthritis drug shows sustained safety and efficacy
- Study supports cardiovascular safety of naproxen
- Cangene chickenpox drug granted orphan status
- Reata brain cancer therapy shows strong activity
- Novartis diabetes drug faces three month delay
- Favrille drug fails secondary goal
- Neurogen commences human testing of obesity drug
- Aeterna prostate cancer drug shows promise
- Isis says new drug effective against cholesterol